Bio-Rad Co-Ownership Defense Fails At The CAFC

B
BakerHostetler

Contributor

BakerHostetler logo
Recognized as one of the top firms for client service, BakerHostetler is a leading national law firm that helps clients around the world address their most complex and critical business and regulatory issues. With five core national practice groups — Business, Labor and Employment, Intellectual Property, Litigation, and Tax — the firm has more than 970 lawyers located in 14 offices coast to coast. BakerHostetler is widely regarded as having one of the country’s top 10 tax practices, a nationally recognized litigation practice, an award-winning data privacy practice and an industry-leading business practice. The firm is also recognized internationally for its groundbreaking work recovering more than $13 billion in the Madoff Recovery Initiative, representing the SIPA Trustee for the liquidation of Bernard L. Madoff Investment Securities LLC. Visit bakerlaw.com
On April 29, 2021, the CAFC affirmed an ITC decision holding the importation and sale by Bio-Rad Laboratories, Inc. of certain microfluidic systems and components used for gene sequencing or related analyses infringed certain ...
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

On April 29, 2021, the United States Court of Appeals for the Federal Circuit (CAFC) affirmed an International Trade Commission (ITC) decision holding the importation and sale by Bio-Rad Laboratories, Inc. (Bio-Rad) of certain microfluidic systems and components used for gene sequencing or related analyses infringed certain 10X Genomics Inc. (10X) patent claims and, moreover, that 10X practiced the patent claims satisfying the requirement of a domestic industry.

In particular, the CAFC decision included an analysis of the ITC determinations regarding both infringement and the domestic industry requirement by Bio-Rad and 10X. However, we will focus on an argument advanced by Bio-Rad regarding a co-ownership defense.

More specifically, a number of inventors of the 10X patents had previously worked for Bio-Rad. Accordingly, as an affirmative defense, Bio-Rad claimed that it co-owned the asserted 10X patents by advancing arguments that the inventors conceived of the ideas embodied in the 10X patents while they were still employed by Bio-Rad and/or its predecessor company.

During the ITC proceeding, an Administrative Law Judge (ALJ) rejected the defense by concluding that Bio-Rad had not shown that the "inventive concept" of the asserted patents was conceived before the inventors left Bio-Rad. On review, the Commission agreed with the ALJ.

In particular, Bio-Rad argued that while working at Bio-Rad (or its predecessor company), the inventors had ideas that contributed to the post-employment inventions at issue, which required assignment of their co-ownership interest to Bio-Rad.

However, the CAFC indicated that the evidence argued by Bio-Rad that included, inter alia, certain slides and an email failed to support the co-inventorship contention of the 10X patents being conceived by the inventors while they were employed by Bio-Rad. Additionally, as to the possibility of post-employment conception by the inventors, the CAFC analyzed the assignment provisions and noted that they were limited temporally and the applicable governing law of California provided a confirmatory reason not to read the assignment provisions at issue more broadly. Additionally, the CAFC provided analysis of various decisions cited by Bio-Rad, and the CAFC held that these decisions, as applicable, supported a position that an assignment provision was limited to intellectual property developed during the term of employment. Accordingly, the CAFC affirmed the ITC decision.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More